Managing comorbidities in COPD

References

• RabeKFHurdSAnzuetoAGlobal strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2007176653255517507545
   PubMed Web of Science ®Google Scholar
• World Health OrganizationChronic obstructive pulmonary disease (COPD)2011 Available from: http://www.who.int/respiratory/copdAccessed September 25, 2014
   Google Scholar
• ChatilaWMThomashowBMMinaiOACrinerGJMakeBJComorbidities in chronic obstructive pulmonary diseaseProc Am Thorac Soc20085454955518453370
   PubMedGoogle Scholar
• TsiligianniIGKosmasEVan der MolenTTzanakisNManaging comorbidity in COPD: a difficult taskCurr Drug Targets201314215817623256716
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung DiseaseGlobal strategy for the diagnosis, management and prevention of chronic obstructive pulmonary disease Revised2014 Available from: http://www.goldcopd.org/guidelines-global-strategy-for-diagnosis-management.htmlAccessed September 14, 2014
   Google Scholar
• KoskelaJKilpeläinenMKupiainenHCo-morbidities are the key nominators of the health related quality of life in mild and moderate COPDBMC Pulm Med201414110224946786
   PubMed Web of Science ®Google Scholar
• ValderasJMStarfieldBSibbaldBSalisburyCRolandMDefining comorbidity: implications for understanding health and health servicesAnn Fam Med20097435736319597174
   PubMed Web of Science ®Google Scholar
• BowerPMacdonaldWHarknessEMultiborbidity, service organization and clinical decision making in primary care: a qualitative studyFam Pract201128557958721613378
   PubMed Web of Science ®Google Scholar
• MacNeeWSystemic inflammatory biomarkers and co-morbidities of chronic obstructive diseaseAnn Med201345329130023110517
   PubMed Web of Science ®Google Scholar
• DivoMCoteCde TorresJPComorbidities and risk of mortality in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2012186215516122561964
   PubMed Web of Science ®Google Scholar
• CorsonelloAAntonelli IncalziRPistelliRPedoneCBustacchiniSLattanzioFComorbidities of chronic obstructive pulmonary diseaseCurr Opin Pulm Med201117Suppl 1S21S2822209926
   PubMed Web of Science ®Google Scholar
• SorianoJBVisickGTMuellerovaHPayvandiNHansellALPatterns of comorbidities in newly diagnosed COPD and asthma in primary careChest200512842099210716236861
   PubMed Web of Science ®Google Scholar
• FuJJMcDonaldVMGibsonPGSimpsonJLSystemic inflammation in older adults with asthma-COPD overlap syndromeAllergy Asthma Immunol Res20146431632424991455
   PubMed Web of Science ®Google Scholar
• MarshSETraversJWeatherallMProportional classifications of COPD phenotypesThorax200863976176718728201
   PubMed Web of Science ®Google Scholar
• GibsonPGSimpsonJLThe overlap syndrome of asthma and COPD: what are its features and how important is it?Thorax200964872877519638566
   PubMed Web of Science ®Google Scholar
• HardinMSilvermanEKBarrRGCOPDGene InvestigatorsThe clinical features of the overlap between COPD and asthmaRespir Res20111212721951550
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBSennSA 4-year trial of tiotropium in chronic obstructive pulmonary diseaseN Engl J Med2008359151543155418836213
   PubMed Web of Science ®Google Scholar
• TashkinDPCelliBDecramerMBronchodilator responsiveness in patients with COPDEur Respir J200831474275018256071
   PubMed Web of Science ®Google Scholar
• HurstJRVestboJAnzuetoASusceptibility to exacerbation in chronic obstructive pulmonary diseaseN Engl J Med2010363121128113820843247
   PubMed Web of Science ®Google Scholar
• Global Initiative for AsthmaDiagnosis of diseases of chronic airflow limitation: asthma COPD and asthma-COPD overlap syndrome (ACOS) Available from: http://www.ginasthma.org/local/uploads/files/AsthmaCOPDOverlap.pdfAccessed September 14, 2014
   Google Scholar
• KiriVASorianoJVisickGFabbriLRecent trends in lung cancer and its association with COPD: an analysis using the UK GP Research DatabasePrim Care Respir J2010191576119756330
   PubMedGoogle Scholar
• TammemagiCMNeslund-DudasCSimoffMKvalePImpact of comorbidity on lung cancer survivalInt J Cancer2003103679280212516101
   PubMed Web of Science ®Google Scholar
• LoganathanRSStoverDEShiWVenkatramanEPrevalence of COPD in women compared to men around the time of diagnosis of primary lung cancerChest200612951305131216685023
   PubMed Web of Science ®Google Scholar
• YoungRPHopkinsRJChristmasTBlackPNMetcalfPGambleGDCOPD prevalence is increased in lung cancer, independent of age, sex and smoking historyEur Respir J200934238038619196816
   PubMed Web of Science ®Google Scholar
• CavaillèsABrinchault-RabinGDixmierAComorbidities of COPDEur Respir Rev20132213045447524293462
   PubMedGoogle Scholar
• SinDDAnthonisenNRSorianoJBAgustiAGMortality in COPD: the role of comorbiditiesEur Respir J20062861245125717138679
   PubMed Web of Science ®Google Scholar
• AnthonisenNRSkeansMAWiseRAManfredaJKannerREConnettJELung Health Study Research GroupThe effects of a smoking cessation intervention on 14.5-year mortality: a randomized clinical trialAnn Intern Med2005142423323915710956
   PubMed Web of Science ®Google Scholar
• Garcia-AymerichJFarreroEFelezMARisk factors of readmission to hospital for a COPD exacerbation: a prospective studyThorax200358210010512554887
   PubMed Web of Science ®Google Scholar
• WashkoGRHunninghakeGMFernanzezIECOPDGene InvestigatorsLung volumes and emphysema in smokers with interstitial lung abnormalitiesN Engl J Med20113641089790621388308
   PubMed Web of Science ®Google Scholar
• SchonhoferBWenzelMGeibelMKöhlerDBlood transfusion and lung function in chronically anemic patients with severe chronic obstructive pulmonary diseaseCrit Care Med19982611182418289824074
   PubMed Web of Science ®Google Scholar
• MillerJEdwardsLDAgustíAEvaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) InvestigatorsComorbidity, systemic inflammation and outcomes in the ECLIPSE cohortRespir Med201310791376138423791463
   PubMed Web of Science ®Google Scholar
• ErikssonBLindbergAMuellerovaHRönmarkELundbäckBAssociation of heart diseases with COPD and restrictive lung function – results from a population surveyRespir Med201310719810623127573
   PubMed Web of Science ®Google Scholar
• Le JemtelTHPadelettiMJelicSDiagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failureAm J Coll Cardiol2007492171180
   PubMed Web of Science ®Google Scholar
• RuttenFHCramerMJLammersJWGrobbeeDEHoesAWHeart failure and chronic obstructive pulmonary disease: an ignored combination?Eur J Heart Fail200687707711
   Web of Science ®Google Scholar
• SidneySSorelMQuesenberryCPJrDeLuiseCLanesSEisnerMDCOPD and incident cardiovascular disease. Hospitalizations and mortality: Kaiser Permanente Medical Care ProgramChest200512842068207516236856
   PubMed Web of Science ®Google Scholar
• Garcia-RodriguezLAWallanderMAMartin-MerinoEJohanssonSHeart failure, myocardial infarction, lung cancer and death in COPD patients: a UK primary care studyRespir Med2010104111691169920483577
   PubMed Web of Science ®Google Scholar
• MascarenhasJLourencoPLopesRAzevedoABettencourtPChronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implicationsAm Heart J2008155352152518294490
   PubMed Web of Science ®Google Scholar
• FranssenFMRochesterCLComorbidities in patients with COPD and pulmonary rehabilitation: do they matter?Eur Respir Rev20142313113114124591670
   PubMedGoogle Scholar
• RuttenFHVonkenEJCramerMJCardiovascular magnetic resonance imaging to identify left-sided chronic heart failure in stable patients with chronic obstructive pulmonary diseaseAm Heart J2008156350651218760133
   PubMed Web of Science ®Google Scholar
• SinDDManSFChronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortalityProc Am Thorac Soc20052181116113462
   PubMedGoogle Scholar
• BrekkePHOmlandTSmithPSøysethVUnderdiagnosis of myocardial infarction in COPD – Cardiac Infarction Injury Score (CIIS) in patients hospitalised for COPD exacerbationRespir Med200810291243124718595681
   PubMed Web of Science ®Google Scholar
• SinDDManSFWhy are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary diseaseCirculation2003107111514151912654609
   PubMed Web of Science ®Google Scholar
• HuangBYangYZhuJClinical characteristics and prognostic significance of chronic obstructive pulmonary disease in patients with atrial fibrillation: results from a multicenter atrial fibrillation registry studyJ Am Med Dir Assoc201415857658124894999
   PubMed Web of Science ®Google Scholar
• KonecnyTParkJYSomersKRRelation of chronic obstructive pulmonary disease to atrial and ventricular arrhythmiasAm J Cardiol2014114227227724878126
   PubMed Web of Science ®Google Scholar
• LiJAgarwalSKAlonsoAAirflow obstruction, lung function, and incidence of atrial fibrillation: the Atherosclerosis Risk in Communities (ARIC) studyCirculation2014129997198024344084
   PubMed Web of Science ®Google Scholar
• Zoni-BerissoMLercariFCarazzaTDomenicucciSEpidemiology of atrial fibrillation: European perspectiveClin Epidemiol2014621322024966695
   PubMed Web of Science ®Google Scholar
• GulsvikAHansteenVSivertssenECardiac arrhythmias in patients with serious pulmonary diseasesSand J Respir Dis1978593154159
   PubMedGoogle Scholar
• HayashiTFukamizuSHojoRPrevalence and electrophysiological characteristics of typical atrial flutter in patients with atrial fibrillation and chronic obstructive pulmonary diseaseEuropace201315121777178323787904
   PubMed Web of Science ®Google Scholar
• ChaouatANaeijeRWeitzenblumEPulmonary hypertension in COPDEur Respir J20083251371138518978137
   PubMed Web of Science ®Google Scholar
• ChaouatABugnetASKadaouiNSevere pulmonary hypertension and chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2005172218919415831842
   PubMed Web of Science ®Google Scholar
• JyothulaSSafdarZUpdate on pulmonary hypertension complicating chronic obstructive pulmonary diseaseInt J Chron Obstruct Pulmon Dis2009435136319802350
   PubMedGoogle Scholar
• WeitzenblumESautegeauAEhrhartMMammosserMPelletierALong-term oxygen therapy can reverse the progression of pulmonary hypertension in patients with chronic obstructive pulmonary diseaseAm Rev Respir Dis198513144934983922267
   PubMed Web of Science ®Google Scholar
• Tillie-LeblondIMarquetteCHPerezTPulmonary embolism in patients with unexplained exacerbation of chronic obstructive pulmonary disease: prevalence and risk factorsAnn Intern Med2006144639039616549851
   PubMed Web of Science ®Google Scholar
• GunenHGulbasGInEYetkinOHacievliyagilSSVenous thromboemboli and exacerbations of COPDEur Respir J20103561243124819926740
   PubMed Web of Science ®Google Scholar
• ChenWJLinCCLinCYPulmonary embolism in chronic obstructive pulmonary disease: a population-based cohort studyCOPD201411443844325010753
   PubMedGoogle Scholar
• PeinadoVIBarberaJARamirezJEndothelial dysfunction in pulmonary arteries of patients with mild COPDAm J Physiol19982746 Pt 1908913
   PubMed Web of Science ®Google Scholar
• BarrRGMesia-VelaSAustinJHImpaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: the Emphysema and Cancer Action Project (EMCAP) StudyAm J Respir Crit Care Med2007176121200120717761614
   PubMed Web of Science ®Google Scholar
• SabitRThomasPShaleDJCollinsPLinnaneSJThe effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPDChest20101381475120154074
   PubMed Web of Science ®Google Scholar
• UndasAKaczmarekPSladekKFibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatmentThromb Haemost200910261176118219967149
   PubMed Web of Science ®Google Scholar
• DoehnerWHaeuslerKGEndresMAnkerSDMacNeeWLainscakMNeurological and endocrinological disorders: orphans in chronic obstructive pulmonary diseaseRespir Med2011105Suppl 11219
   Web of Science ®Google Scholar
• VaidyulaVRCrinerGJGrabianowskiCRaoAKCirculating tissue factor procoagulant activity is elevated in stable moderate to severe chronic obstructive pulmonary diseaseThromb Res2009124325926119162305
   PubMed Web of Science ®Google Scholar
• HozawaABillingsJLShaharEOhiraTRosamondWDFolsomARLung function and ischemic stroke incidence: the Atherosclerosis Risk in Communities studyChest200613061642164917166977
   PubMed Web of Science ®Google Scholar
• FinkelsteinJChaEScharfSMChronic obstructive pulmonary disease as an independent risk factor for cardiovascular morbidityInt J Chron Obstruct Pulmon Dis2009433734919802349
   PubMedGoogle Scholar
• McGarveyLPJohnMAndersonJAZvarichMWiseRATORCH Clinical Endpoint CommitteeAscertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint CommitteeThorax200762541141517311843
   PubMed Web of Science ®Google Scholar
• CrisafulliECostiSLuppiFRole of comorbidities in a cohort of patients with COPD undergoing pulmonary rehabilitationThorax200863648749218203818
   PubMed Web of Science ®Google Scholar
• CazzolaMBettoncelliGSessaECricelliCBiscioneGPrevalence of comorbidities in patients with chronic obstructive pulmonary diseaseRespiration201080211211920134148
   PubMed Web of Science ®Google Scholar
• ManninoDMThornDSwensenAHolguinFPrevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPDEur Respir J200832496296918579551
   PubMed Web of Science ®Google Scholar
• SongYKlevakAMansonJEBuringJELiuSAsthma, chronic obstructive pulmonary disease, and type 2 diabetes in the Women’s Health StudyDiabetes Res Clin Pract201090336537120926152
   PubMed Web of Science ®Google Scholar
• EhrlichSFQuesenberryCPJrVan Den EedenSKShanJFerraraAPatients diagnosed with diabetes are at increased risk for asthma, chronic obstructive pulmonary disease, pulmonary fibrosis, and pneumonia but not lung cancerDiabetes Care2010331556019808918
   PubMed Web of Science ®Google Scholar
• FearyJRRodriguesLCSmithCJHubbardRBGibsonJPrevalence of major comorbidities in subjects with COPD and incidence of myocardial infarction and stroke: a comprehensive analysis using data from primary careThorax2010651195696220871122
   PubMed Web of Science ®Google Scholar
• TkacovaRSystemic inflammation in chronic obstructive pulmonary disease: may adipose tissue play a role? Review of the literature and future perspectivesMediators Inflamm2010201058598920414465
   PubMed Web of Science ®Google Scholar
• FabbriLMLuppiFBeghéBRabeKFComplex chronic comorbidities of COPDEur Respir J200831120421218166598
   PubMed Web of Science ®Google Scholar
• Emerging Risk Factors CollaborationSeshasaiSRKaptogeSThompsonADiabetes mellitus, fasting glucose, and risk of cause-specific deathN Engl J Med2011364982984121366474
   PubMed Web of Science ®Google Scholar
• BakerEHJanawayCHPhilipsBJHyperglycaemia is associated with poor outcomes in patients admitted to hospital with acute exacerbations of chronic obstructive pulmonary diseaseThorax200661428428916449265
   PubMed Web of Science ®Google Scholar
• ParappilADepczynskiBCollettPMarksGBEffect of comorbid diabetes on length of stay and risk of death in patients admitted with acute exacerbations of COPDRespirology201015691892220546185
   PubMed Web of Science ®Google Scholar
• WatanabeRTanakaTAitaKOsteoporosis is highly prevalent in Japanese males with chronic obstructive pulmonary disease and is associated with deteriorated pulmonary functionJ Bone Miner Metab752014 [Epub ahead of print.]
   Web of Science ®Google Scholar
• FergusonGTCalverleyPMAndersonJAPrevalence and progression of osteoporosis in patients with COPD: results from the Towards a Revolution in COPD Health StudyChest200913661456146519581353
   PubMed Web of Science ®Google Scholar
• Graat-VerboomLWoutersEFSmeenkFWvan den BorneBELundeRSpruitMACurrent status of research on osteoporosis in COPD: a systematic reviewEur Respir J200934120921819567604
   PubMed Web of Science ®Google Scholar
• JanssensWBouillonRClaesBVitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding geneThorax201065321522019996341
   PubMed Web of Science ®Google Scholar
• MaggiSSivieroPGonnelliSEOLO Study GroupOsteoporosis risk in patients with chronic obstructive pulmonary disease: the EOLO studyJ Clin Densitom200912334535219647671
   PubMed Web of Science ®Google Scholar
• ScanlonPDConnettJEWiseRALung Health Study Research GroupLoss of bone density with inhaled triamcinolone in Lung Health Study IIAm J Respir Crit Care Med2004170121302130915374846
   PubMed Web of Science ®Google Scholar
• AgustiASorianoJBCOPD as a systemic diseaseCOPD20085213313818415812
   PubMedGoogle Scholar
• RuttenEPBreyerMKSpruitMAAbdominal fat mass contributes to the systemic inflammation in chronic obstructive pulmonary diseaseClin Nutr201029675676020566396
   PubMed Web of Science ®Google Scholar
• SeymourJMSpruitMAHopkinsonNSThe prevalence of quadriceps weakness in COPD and the relationship with disease severityEur Respir J2010361818819897554
   PubMed Web of Science ®Google Scholar
• CielenNMaesKGayan-RamirezGMusculoskeletal disorders in chronic obstructive pulmonary diseaseBiomed Res Int2014201496576424783225
   PubMed Web of Science ®Google Scholar
• DecramerMJanssensWMiravitllesMChronic obstructive pulmonary diseaseLancet201237998231341135122314182
   PubMed Web of Science ®Google Scholar
• EngelenMPScholsAMDoesJDWoutersEFSkeletal muscle weakness is associated with wasting of extremity fat-free mass but not with airflow obstruction in patients with chronic obstructive pulmonary diseaseAm J Clin Nutr200071373373810702166
   PubMed Web of Science ®Google Scholar
• [No authors listed]Skeletal muscle dysfunction in chronic obstructive pulmonary disease. A statement of the American Thoracic Society and European Respiratory SocietyAm J Respir Crit Care Med19991594 Pt 21409872811
   PubMed Web of Science ®Google Scholar
• KunikMERoundyKVeazeyCSurprisingly high prevalence of anxiety and depression in chronic breathing disordersChest200512741205121115821196
   PubMed Web of Science ®Google Scholar
• BarrRGCelliBRManninoDMComorbidities, patient knowledge, and disease management in a national sample of patients with COPDAm J Med2009122434835519332230
   PubMed Web of Science ®Google Scholar
• NorwoodRPrevalence and impact of depression in chronic obstructive disease patientsCurr Opin Pulm Med200612211311716456380
   PubMed Web of Science ®Google Scholar
• PoolerABeechRExamining the relationship between anxiety and depression and exacerbations of COPD which result in hospital admission: a systematic reviewInt J Chron Obstruct Pulmon Dis2014931533024729698
   PubMed Web of Science ®Google Scholar
• SpitzerCGläserSGrabeHJMental health problems, obstructive lung disease and lung function: findings from the general populationJ Psychosom Res201171317417921843753
   PubMed Web of Science ®Google Scholar
• RegvatJZmitekAVegnutiMKošnikMŠuškovičSAnxiety and depression during hospital treatment of exacerbation of chronic obstructive pulmonary diseaseJ Int Med Res20113931028103821819737
   PubMed Web of Science ®Google Scholar
• AbramsTEVaughan-SarrazinMVan der WegMWAcute exacerbations of chronic obstructive pulmonary disease and the effect of existing psychiatric comorbidity on subsequent mortalityPsychosomatics201152544144921907063
   PubMed Web of Science ®Google Scholar
• LaurinCLavoieKLBaconSLSex differences in the prevalence of psychiatric disorders and psychological distress in patients with COPDChest2007132114815517505033
   PubMed Web of Science ®Google Scholar
• Paz-DiazHMontes de OcaMLopezJMCelliBRPulmonary rehabilitation improves depression, anxiety, dyspnea and health status in patients with COPDAm J Phys Med Rehabil2007861303617304686
   PubMed Web of Science ®Google Scholar
• SchneiderCJickSSBothnerUMeierCRCOPD and the risk of depressionChest2010137234134719801582
   PubMed Web of Science ®Google Scholar
• Al-shairKDockryRMallia-MilanesBKolsumUSinghDVestboJDepression and its relationship with poor exercise capacity, BODE index and muscle wasting in COPDRespir Med2009103101572157919560330
   PubMed Web of Science ®Google Scholar
• OmachiTAKatzPPYelinEHDepression and health-related quality of life in chronic obstructive pulmonary diseaseAm J Med20091128778. e9e1519635280
   PubMed Web of Science ®Google Scholar
• DiMatteoMRLepperHSCroghanTWDepression is a risk factor for noncompliance with medical treatment: meta-analysis of the effects of anxiety and depression on patient adherenceArch Intern Med2000160142101210710904452
   PubMed Web of Science ®Google Scholar
• XuWColletJPShapiroSIndependent effect of depression and anxiety on chronic obstructive pulmonary disease exacerbations and hospitalizationsAm J Respir Crit Care Med2008178991392018755925
   PubMed Web of Science ®Google Scholar
• JenningsJHDigiovineBObeidDFrankCThe association between depressive symptoms and acute exacerbations of COPDLung2009187212813519198940
   PubMed Web of Science ®Google Scholar
• NgTPNitiMTanWCCaoZOngKCEngPDepressive symptoms and chronic obstructive pulmonary disease: effect on mortality, hospital readmission, symptom burden, functional status, and quality of lifeArch Intern Med20071671606717210879
   PubMed Web of Science ®Google Scholar
• YohannesAMBalwinRCConnollyMJPrevalence of sub-threshold depression in elderly patients with chronic obstructive pulmonary diseaseInt J Geriatr Psychiatry200318541261612766917
   PubMed Web of Science ®Google Scholar
• QianJSimoni-WastilaLLangenbergPEffects of depression diagnosis and antidepressant treatment on mortality in Medicare beneficiaries with chronic obstructive pulmonary diseaseJ Am Geriatr Soc201361575476123617752
   PubMed Web of Science ®Google Scholar
• KrachmanSMinaiOAScharfSMSleep abnormalities and treatment in emphysemaProc Am Thorac Soc20085453654218453368
   PubMedGoogle Scholar
• MachadoMCVollmerWMTogeiroSMCPAP and survival in moderate-to-severe obstructive sleep apnoea syndrome and hypoxaemic COPDEur Respir J201035113213719574323
   PubMed Web of Science ®Google Scholar
• MarinJMSorianoJBCarrizoSJBoldovaACelliBROutcomes in patients with chronic obstructive pulmonary disease and obstructive sleep apnea: the overlap syndromeAm J Respir Crit Care Med2010182332533120378728
   PubMed Web of Science ®Google Scholar
• McNicholasWTChronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular diseaseAm J Respir Crit Care Med2009180869270019628778
   PubMed Web of Science ®Google Scholar
• VestboJHurdSSAgustíAGGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summaryAm J Respir Crit Care Med2013187434736522878278
   PubMed Web of Science ®Google Scholar
• TeradaKMuroSSatoSImpact of gastro-oesophageal reflux disease symptoms on COPD exacerbationThorax2008631195195518535116
   PubMed Web of Science ®Google Scholar
• KempainenRRSavikKWhelanTPDunitzJMHerringtonCSBillingsJLHigh prevalence of proximal and distal gastroesophageal reflux disease in advanced COPDChest200713161666167117400682
   PubMed Web of Science ®Google Scholar
• MokhlesiBMorrisALHuangCFCurcioAJBarrettTAKampDWIncreased prevalence of gastroesophageal reflux symptoms in patients with COPDChest200111941043104811296167
   PubMed Web of Science ®Google Scholar
• Rascon-AguilarIEPamerMWludykaPRole of gastroesophageal reflux symptoms in exacerbations of COPDChest200613041096110117035443
   PubMed Web of Science ®Google Scholar
• MapelDWMartonJPPrevalence of renal and hepatobiliary disease, laboratory abnormalities, and potentially toxic medication exposures among persons with COPDInt J Chron Obstruct Pulmon Dis2013812713423515180
   PubMed Web of Science ®Google Scholar
• ChenCYHsuTWMaoSJAbnormal renal resistive index in patients with mild-to-moderate chronic obstructive pulmonary diseaseCOPD201310221622523547633
   PubMedGoogle Scholar
• IncalziRACorsonelloAPedoneCBattagliaSPaglinoGBelliaVExtrapulmonary Consequences of COPD in the Elderly Study InvestigatorsChronic renal failure: a neglected comorbidity of COPDChest2010137483183719903974
   PubMed Web of Science ®Google Scholar
• GjerdeBBakkePSUelandTHardieJAEaganTMThe prevalence of undiagnosed renal failure in a cohort of COPD patients in western NorwayRespir Med2012106336136622129490
   PubMed Web of Science ®Google Scholar
• BarnesPJChronic obstructive pulmonary disease: effects beyond the lungsPLoS Med201073e100022020305715
   PubMed Web of Science ®Google Scholar
• FletcherMJUptonJTaylor-FishwickJCOPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age populationBMC Public Health20111161221806798
   PubMed Web of Science ®Google Scholar
• YoungRPWhittingtonCFHopkinsRJChromosome 4q31 locus in COPD is also associated with lung cancerEur Respir J20103661375138221119205
   PubMed Web of Science ®Google Scholar
• YoungRPHopkinsRJHayBAEptonMJBlackPNGambleGDLung cancer gene associated with COPD: triple whammy or possible confounding effect?Eur Respir J20083251158116418978134
   PubMed Web of Science ®Google Scholar
• HanssonGKInflammation, atherosclerosis, and coronary artery diseaseN Engl J Med200535261685169515843671
   PubMed Web of Science ®Google Scholar
• EickhoffPValipourAKissDDeterminants of systemic vascular function in patients with stable chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2008178121211121818836149
   PubMed Web of Science ®Google Scholar
• MirrakhimovAEChronic obstructive pulmonary disease and glucose metabolism: a bitter sweet symphonyCardiovasc Diabetol20121113223101436
   PubMed Web of Science ®Google Scholar
• BarnesPJCelliBRSystemic manifestations and comorbidities of COPDEur Respir J20093351165118519407051
   PubMed Web of Science ®Google Scholar
• FabbriLMRabeKFFrom COPD to chronic systemic inflammatory syndrome?Lancet2007370958979779917765529
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBCardiovascular events in patients with COPD: TORCH study resultsThorax201065871972520685748
   PubMed Web of Science ®Google Scholar
• CalverleyPMAndersonJACelliBSalmeterol and fluticasone propionate and survival in chronic obstructive pulmonary diseaseN Engl J Med2007356877578917314337
   PubMed Web of Science ®Google Scholar
• WedzichaJACaverleyPMSeemungalTAHaganGAnsariZStockleyRAINSPIRE InvestigatorsThe prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromideAm J Respir Crit Care Med20081771192617916806
   PubMed Web of Science ®Google Scholar
• BarrRGBourbeauJCamargoCAJrRamFSInhaled tiotropium for stable chronic obstructive pulmonary disease: a meta-analysisThorax2006611085486216844726
   PubMed Web of Science ®Google Scholar
• ValenteSPasciutoGBernabeiRCorboGMDo we need different treatments for very elderly COPD patients?Respiration201080535736820733280
   PubMed Web of Science ®Google Scholar
• PasqualeMKSunSXSongFHartnettHJStemkowskiSAImpact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare populationInt J Chron Obstruct Pulmon Dis2012775776423152680
   PubMed Web of Science ®Google Scholar
• OrnekTTorMAltinRClinical factors affecting the direct cost of patients hospitalized with acute exacerbation of chronic obstructive pulmonary diseaseInt J Med Sci20129428529022701335
   PubMed Web of Science ®Google Scholar
• PatelJGNagarSPDalalAAIndirect costs in chronic obstructive pulmonary disease: a review of the economic burden on employers and individuals in the United StatesInt J Chron Obstruct Pulmon Dis2014928930024672234
   PubMed Web of Science ®Google Scholar
• National Heart, Lung, and Blood InstituteMorbidity and Mortality 2009: Chart Book on Cardiovascular, Lung and Blood DiseasesBethesda, MD, USANational Institutes of Health2009
   Google Scholar
• HalpinDMMiravitllesMChronic obstructive pulmonary disease: the disease and its burden to societyProc Am Thorac Soc20063761962316963544
   PubMedGoogle Scholar
• MapelDWHurleyJSFrostFJPetersenHVPicchiMACoultasDBHealth care utilization in chronic obstructive pulmonary disease. A case-control study in a health maintenance organizationArch Intern Med2000160172653265810999980
   PubMed Web of Science ®Google Scholar
• Simon-TuvalTScharfSMMaimonNBernhard-ScharfBJReuveniHTarasiukADeterminants of elevated healthcare utilization in patients with COPDRespir Res201112721232087
   PubMed Web of Science ®Google Scholar
• ManninoDMWattGHoleDThe natural history of chronic obstructive pulmonary diseaseEur Respir J200627362764316507865
   PubMed Web of Science ®Google Scholar
• DoosLUttleyJOnyiaIIqbalZJonesPWKadamUTMosaic segmentation, COPD and CHF multimorbidity and hospital admission costs: a clinical linkage studyJ Public Health (Oxf)201436231732423903003
   PubMed Web of Science ®Google Scholar
• DarnellKDwivediAKWengZPanosRJDisproportionate utilization of healthcare resources among veterans with COPD: a retrospective analysis of factors associated with COPD healthcare costCost Eff Resour Alloc2013111323763761
   PubMedGoogle Scholar
• HillemanDDewanNMaleskerMFriedmanMPharmacoeconomic evaluation of COPDChest200011851278128511083675
   PubMed Web of Science ®Google Scholar
• TeoWTanWSChongWEconomic burden of chronic obstructive pulmonary diseaseRespirology201217112012621954985
   PubMed Web of Science ®Google Scholar
• SharafkhanehAPetersenNYuHJDalalAAJohnsonMLHananiaNABurden of COPD in a government health care system: a retrospective observational study using data from the US Veterans Affairs populationInt J Chron Obstruct Pulmon Dis2010512513220461144
   PubMedGoogle Scholar
• FumagalliGFabianiFForteSINDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology unitsMultidiscip Respir Med2013812823551874
   PubMed Web of Science ®Google Scholar
• GiardinoNDCurtisJLAndreiACNETT Research GroupAnxiety is associated with diminished exercise performance and quality of life in severe emphysema: a cross-sectional studyRespir Res2010112920214820
   PubMed Web of Science ®Google Scholar
• van ManenJGBindelsPJDekkerEWAdded value of co-morbidity in predicting health-related quality of life in COPD patientsRespir Med200195649650411421508
   PubMed Web of Science ®Google Scholar
• MiyazakiMNakamuraHChubachiSKeio COPD Comorbidity Research (K-CCR) GroupAnalysis of comorbid factors that increase the COPD assessment test scoresRespir Res2014151324502760
   PubMed Web of Science ®Google Scholar
• HallSFA user’s guide to selecting a comorbidity index for clinical researchJ Clin Epidemiol200659884985516828679
   PubMed Web of Science ®Google Scholar
• CharlsonMEPompeiPAlesKLMacKenzieCRA new method of classifying prognostic comorbidity in longitudinal studies: development and validationJ Chronic Dis19874053733383558716
   PubMedGoogle Scholar
• FreiAMuggensturmPPutchaNFive comorbidities reflected the health status in patients with chronic obstructive pulmonary disease: the newly developed COMCOLD indexJ Clin Epidemiol201467890491124786594
   PubMed Web of Science ®Google Scholar
• HawkinsNMPetrieMCMacdonaldMRHeart failure and chronic obstructive pulmonary disease: the quandary of beta-blockers and beta-agonistsJ Am Coll Cardiol201157212127213821596228
   PubMed Web of Science ®Google Scholar
• CelliBDecramerMLeimerIVogelUKestenSTashkinDPCardiovascular safety of tiotropium in patients with COPDChest20101371203019592475
   PubMed Web of Science ®Google Scholar
• McMurrayJJAdamopoulosSAnkerSDESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012: the Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESCEur Heart J201233141787184722611136
   PubMed Web of Science ®Google Scholar
• Van der HooftCSHeeringaJBrusselleGGCorticosteroids and the risk of atrial fibrillationArch Intern Med200616691016102016682576
   PubMedGoogle Scholar
• WaltersJAWaltersEHWood-BakerROral corticosteroids for stable chronic obstructive pulmonary diseaseCochrane Database Syst Rev20053CD00537416034972
   PubMedGoogle Scholar
• HuertaCLanesSFGarcia RodriguezLARespiratory medications and the risk of cardiac arrhythmiasEpidemiology200516336036615824553
   PubMed Web of Science ®Google Scholar
• PageCCazzolaMBifunctional drugs for the treatment of asthma and obstructive pulmonary diseaseEur Respir J201444247548224696121
   PubMed Web of Science ®Google Scholar
• LeeDSMarkwardtSMcAvayGJEffect of β-blockers on cardiac and pulmonary events and death in older adults with cardiovascular disease and chronic obstructive pulmonary diseaseMed Care20145234551
   Web of Science ®Google Scholar
• ForesiACavigioliGSignorelliGPozzoniMBOlivieriDIs the use of beta-blockers in COPD still an unresolved dilemma?Respiration201080317718720639691
   PubMed Web of Science ®Google Scholar
• MateraMGMartuscelliECazzolaMPharmacological modulation of beta-adrenoceptor function in patients with coexisting chronic obstructive pulmonary disease and chronic heart failurePulm Pharmacol Ther20102311819833222
   PubMed Web of Science ®Google Scholar
• GottliebSSMcCarterRJVogelRAEffect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarctionN Engl J Med199833984894979709041
   PubMed Web of Science ®Google Scholar
• PetersenHSoodAMeekPMRapid lung function decline in smokers is a risk factor for COPD and is attenuated by angiotensin-converting enzyme inhibitor useChest2014145469570324008986
   PubMed Web of Science ®Google Scholar
• ForthRMontgomeryHACE in COPDQ a therapeutic target?Thorax200358755655812832663
   PubMed Web of Science ®Google Scholar
• ReinerZCatapanoALDe BackerGESC Committee for Practice Guidelines (CPG) 2008–2010 and 2010–2012 CommitteesESC/EAS Guidelines for the managements of dyslipidaemias: the Task Force for the managements of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS)Eur Heart J201132141769181821712404
   PubMed Web of Science ®Google Scholar
• CorsonelloAPedoneCCoricaFGruppo Italiano di Farmacovigilanza nell’Anziano (GIFA) InvestigatorsConcealed renal insufficiency and adverse drug reactions in elderly hospitalized patientsArch Intern Med2005165779079515824299
   PubMedGoogle Scholar
• TanKHDe CossartLEdwardsPRExercise training and peripheral vascular diseaseBr J Surg200087555356210792309
   PubMed Web of Science ®Google Scholar
• BennellKLHinmanRSA review of the clinical evidence for exercise in osteoarthritis of the hip and kneeJ Sci Med Sport20111414920851051
   PubMed Web of Science ®Google Scholar
• O’GormanDJKrookAExercise and the treatment of diabetes and obesityMed Clin North Am201195595396921855702
   PubMed Web of Science ®Google Scholar
• ThomasDEElliottEJNaughtonGAExercise for type 2 diabetes mellitusCochrane Database Syst Rev20063CD00296816855995
   PubMed Web of Science ®Google Scholar
• MakeBDutroMPPaulose-RamRMartonJPMapelDWUndertreatment of COPD: a retrospective analysis of US managed care and Medicare patientsInt J Chron Obstruct Pulmon Dis201271922315517
   PubMed Web of Science ®Google Scholar
• BlanchetteCMGrossNJAltmanPRising costs of COPD and potential maintenance therapy to slow the trendAm Health Drug Benefits2014729810624991394
   PubMedGoogle Scholar
• AnecchinoCRossiEFanizzaCDe RosaMTognoniGRomeroMWorking Group ARNO ProjectPrevalence of chronic obstructive pulmonary disease and pattern of comorbidities in a general populationInt J Chron Obstruct Pulmon Dis20072456757418268930
   PubMedGoogle Scholar
• Lopez VarelaMVMontes de OcaMHalbertRJPLATINO TeamSex-related differences in COPD in five Latin American cities: the PLATINO studyEur Respir J20103651034104120378599
   PubMed Web of Science ®Google Scholar
• van ManenJGBindelsPJLizermansCJvan der ZeeJSBottemaBJSchadéEPrevalence of comorbidity in patients with chronic airway obstruction and controls over the age of 40J Clin Epidemiol200154328729311223326
   PubMed Web of Science ®Google Scholar